Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2021
Jun. 30, 2020
Current assets:    
Cash and cash equivalents $ 77,404,000 $ 55,112,000
Accounts receivable - trade 426,000 75,000
Settlement receivable - current portion 5,100,000  
Subscription receivable   5,549,000
Investments in debt securities 19,570,000  
Work in progress 27,000 798,000
Prepaid expenses and other current assets 2,070,000 214,000
Total Current Assets 104,597,000 61,748,000
Note receivable and accrued interest 1,556,000  
Settlement receivable - noncurrent portion 5,100,000  
Finance lease right-of-use assets, net of accumulated amortization 26,111,000 27,616,000
Fixed assets, net of accumulated depreciation 8,628,000 3,657,000
Intangible assets, net of accumulated amortization 952,000 1,144,000
Security deposits 24,000 24,000
Total Assets 146,968,000 94,189,000
Current liabilities:    
Accounts payable (related parties of $0 and $6 as of June 30, 2021 and 2020, respectively) 2,254,000 1,759,000
Accrued expenses (related party of $701 and $705 as of June 30, 2021 and 2020, respectively) 3,001,000 1,105,000
Finance lease obligations - current portion 367,000 301,000
Note payable - PPP loan - current portion 600,000 261,000
Deferred revenue / Contract liabilities 423,000 1,810,000
Total Current Liabilities 6,645,000 5,236,000
Note payable - PPP loan - net of current portion 0 339,000
Finance lease obligations - net of current portion 31,755,000 32,007,000
Total Liabilities 38,400,000 37,582,000
Commitments and Contingencies
iBio, Inc. Stockholders’ Equity:    
Common stock - $0.001 par value; 275,000,000 shares authorized at June 30, 2021 and 2020; 217,873,094 and 140,071,110 shares issued and outstanding as of June 30, 2021 and 2020, respectively 217,000 140,000
Additional paid-in capital 282,058,000 206,931,000
Accumulated other comprehensive loss (63,000) (33,000)
Accumulated deficit (173,627,000) (150,420,000)
Total iBio, Inc. Stockholders’ Equity 108,585,000 56,618,000
Noncontrolling interest (17,000) (11,000)
Total Equity 108,568,000 56,607,000
Total Liabilities and Equity $ 146,968,000 $ 94,189,000